{"success":true,"data":{"pressRelease":{"id":"158228","rtpr_id":"nBw8pymw2a-20261001","ticker":"HYFT","exchange":"NASDAQ","all_tickers":["HYFT"],"title":"MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director","author":"Business Wire","published_at":"2026-10-01T12:46:00.091Z","article_body":"MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director\n\nVeteran Banker and Licensed Fiduciary to Serve on the Audit Committee and the\nCompensation, Nomination and Governance Committee\n\nMindWalk Holdings Corp. (\"MindWalk\") (NASDAQ: HYFT), a Bio-Native AI company,\ntoday announced the appointment of Kim Remizowski to its Board of Directors as\nan independent director, effective September 29, 2026. Mr. Remizowski will\nserve on the Audit Committee and the Compensation, Nomination and Governance\nCommittee. The Board has determined that he qualifies as an independent\ndirector under Nasdaq listing rules and as an audit committee financial expert\nunder applicable SEC rules. With this appointment, the Board comprises four\ndirectors, three of whom are independent.\n\nMr. Remizowski most recently served as Director, Private Equity at Vistra, a\nglobal corporate services group operating in more than 50 jurisdictions, where\nhe oversaw governance for a portfolio of investment funds and holding\nstructures. He brings more than 35 years of experience in institutional\nbanking and fiduciary oversight, including board service at Merrill Lynch Bank\nand Trust Company (Cayman) Ltd., Managing Director responsibility at DMS Bank\n& Trust Ltd., and 17 years at Royal Bank of Canada. A Caymanian, he has\nspent the greater part of his career in the Cayman Islands financial services\nsector and is an Accredited Director of the Chartered Governance Institute of\nCanada and a Licensed Director with the Cayman Islands Monetary Authority\n(CIMA).\n\nThe appointment comes as MindWalk expands contracted, recurring platform\ndeployments with life sciences clients on ReefIQ™, the biological data\nsubstrate that provides context for life sciences, powered by HYFT®\nTechnology. Serving regulated life sciences workloads puts data integrity and\ngovernance at the center of the Company's value proposition and raises the\npremium on independent financial and governance oversight at the Board level.\n\n\"Kim brings the kind of governance depth that becomes load-bearing exactly\nwhen a company moves from building technology to deploying it at scale,\" said\nJennifer Bath, PhD, President and Chief Executive Officer of MindWalk. \"We are\nselling infrastructure into regulated life sciences workloads, and the\ncredibility of that position rests as much on the quality of our governance as\non the quality of the science. Kim has spent 35 years inside regulated\nfinancial institutions as a bank director and licensed fiduciary, and he\nbrings that governance discipline to our Board and its committees. We are\npleased to welcome him to the Board.\"\n\n\"MindWalk is building foundational infrastructure for life sciences AI and\nholding itself accountable for how that infrastructure is governed. That is a\ndiscipline I recognize from the institutional side of finance,\" said Mr.\nRemizowski. \"I look forward to working with Dr. Bath, the Chair, and my fellow\ndirectors, and to bringing the rigor of regulated financial oversight to the\nBoard's committees as the Company scales.\"\n\nAbout Kim Remizowski\n\nMr. Remizowski, a Caymanian, has more than 35 years of experience in\ninstitutional banking and fiduciary oversight. Most recently, he served as\nDirector, Private Equity at Vistra, a global corporate services group\noperating in more than 50 jurisdictions, where he oversaw governance for a\nportfolio of investment funds and holding structures and worked across a\nnetwork of fund sponsors, institutional allocators, and family offices in\nNorth America, Europe, Latin America, and the Caribbean.\n\nPreviously, Mr. Remizowski served as Resident Director of Merrill Lynch Bank\nand Trust Company (Cayman) Ltd., Bank of America Merrill Lynch's Cayman Class\nB bank, with overall responsibility for the bank's operation, including its\nloan, deposit, and investment businesses and all regulatory and financial\nreporting to CIMA. He sat on the bank's Board as Director and Secretary, held\ncredit approval authority for international securities-based loans above $10\nmillion, and was a director and authorized signatory of numerous Merrill Lynch\nlegal entities. He also served as Managing Director of DMS Bank & Trust\nLtd., with responsibility for the bank's strategic direction, operations,\nfinance, and compliance, and at Intertrust Group (now CSC), where he led the\nPrivate Client Trust & Corporate team, with $700 million in assets under\nmanagement. Earlier, he was Manager, Banking, Treasury & Operations at\nAall Trust & Banking Corporation, where he was a member of the Executive\nCommittee. He began his career at Royal Bank of Canada, where over 17 years he\nadvanced through branch management, inspection, and operations roles to\nregional responsibility for 13 branches.\n\nMr. Remizowski is an Accredited Director of the Chartered Governance Institute\nof Canada, a Licensed Director with CIMA, a Trust and Estate Practitioner\n(TEP) with STEP, an Associate of the Institute of Canadian Bankers, and a\nCertified Digital Asset Advisor. He maintains an active professional interest\nin the governance of emerging technologies, including artificial intelligence\nand digital assets.\n\nAbout MindWalk Holdings Corp.\n\nMindWalk Holdings Corp. (NASDAQ: HYFT) is a Bio-Native AI company building the\nBioIntelligence infrastructure that life sciences AI and agentic AI require,\nintegrating AI, data, and advanced wet lab capabilities into one connected\ndiscovery ecosystem. At its core is HYFT® Technology, a proprietary,\nfunction-aware representation of biology. Its HYFT fingerprints span sequence\nand structural biology and, refined over 20 years of curation, form a\ncontinuously evolving biological representation of 660 million patterns and 25\nbillion relationships. This enriched biological representation is the\narchitecture behind ReefIQ™, the biological data substrate that provides\ncontext for life sciences, enriching data at ingestion and growing more\nvaluable with each program run on it, and LensAI™, the reasoning and\napplication layer for target discovery, candidate diligence, portfolio\ndecision support, and the agentic AI workflows pharma is racing to deploy. By\ndesign, value compounds in this HYFT representation layer, not in any\nindividual AI model that runs on top of it.\n\nForward-Looking Statements\n\nThis press release contains forward-looking statements within the meaning of\napplicable United States and Canadian securities laws. Forward-looking\nstatements are based on management's current expectations and assumptions and\nare subject to known and unknown risks, uncertainties, and other factors that\nmay cause actual results to differ materially, including: the ability of newly\nappointed directors to contribute to governance, oversight, and strategic\ndirection as anticipated; the risk that a director resigns, is not re-elected,\nor is unable to serve; the Company's ability to maintain compliance with\nNasdaq listing standards, including independence and committee composition\nrequirements; the Company's ability to convert engagement into contracted,\nrecurring platform arrangements and to retain and expand those arrangements;\nthe Company’s ability to attract and retain qualified independent directors;\nthe build-out and certification of compliance and governance capabilities for\nregulated life sciences workloads; market acceptance and commercial outcomes\nof ReefIQ™ and LensAI™; the technical performance of AI-based discovery\nmethods and of the underlying compute infrastructure; intellectual property\nrisks, including the ability to obtain, maintain, defend, and enforce patent\nand other proprietary rights; competition; regulatory determinations; and\ncapital markets, economic, and geopolitical conditions. Additional information\nabout these and other risks is available under “Risk Factors” in\nMindWalk's most recent Annual Report on Form 20-F and other filings on SEDAR+\n(sedarplus.ca) and EDGAR (sec.gov/edgar). Except as required by law, MindWalk\nundertakes no obligation to update any forward-looking statement. Nothing in\nthis press release constitutes investment advice. This press release does not\nconstitute an offer to sell or the solicitation of an offer to buy any\nsecurities.\n\nTrademarks\n\nHYFT® is a registered trademark of MindWalk Holdings Corp. LensAI™ and\nReefIQ™ are trademarks of MindWalk Holdings Corp. or its subsidiaries;\nReefIQ™ registration is pending. All other trademarks are the property of\ntheir respective owners.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20261001631178/en/\n(https://www.businesswire.com/news/home/20261001631178/en/)\n\nInvestor Relations Contact \n\nLouie Toma, CPA, CFA\n\nManaging Director, CoreIR\n\ninvestors@mindwalkai.com (mailto:investors@mindwalkai.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw8pymw2a-20261001","title":"MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director","author":"Business Wire","ticker":"HYFT","created":"2026-10-01T12:46:00.091Z","tickers":["HYFT"],"exchange":"NASDAQ","article_body":"MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director\n\nVeteran Banker and Licensed Fiduciary to Serve on the Audit Committee and the\nCompensation, Nomination and Governance Committee\n\nMindWalk Holdings Corp. (\"MindWalk\") (NASDAQ: HYFT), a Bio-Native AI company,\ntoday announced the appointment of Kim Remizowski to its Board of Directors as\nan independent director, effective September 29, 2026. Mr. Remizowski will\nserve on the Audit Committee and the Compensation, Nomination and Governance\nCommittee. The Board has determined that he qualifies as an independent\ndirector under Nasdaq listing rules and as an audit committee financial expert\nunder applicable SEC rules. With this appointment, the Board comprises four\ndirectors, three of whom are independent.\n\nMr. Remizowski most recently served as Director, Private Equity at Vistra, a\nglobal corporate services group operating in more than 50 jurisdictions, where\nhe oversaw governance for a portfolio of investment funds and holding\nstructures. He brings more than 35 years of experience in institutional\nbanking and fiduciary oversight, including board service at Merrill Lynch Bank\nand Trust Company (Cayman) Ltd., Managing Director responsibility at DMS Bank\n& Trust Ltd., and 17 years at Royal Bank of Canada. A Caymanian, he has\nspent the greater part of his career in the Cayman Islands financial services\nsector and is an Accredited Director of the Chartered Governance Institute of\nCanada and a Licensed Director with the Cayman Islands Monetary Authority\n(CIMA).\n\nThe appointment comes as MindWalk expands contracted, recurring platform\ndeployments with life sciences clients on ReefIQ™, the biological data\nsubstrate that provides context for life sciences, powered by HYFT®\nTechnology. Serving regulated life sciences workloads puts data integrity and\ngovernance at the center of the Company's value proposition and raises the\npremium on independent financial and governance oversight at the Board level.\n\n\"Kim brings the kind of governance depth that becomes load-bearing exactly\nwhen a company moves from building technology to deploying it at scale,\" said\nJennifer Bath, PhD, President and Chief Executive Officer of MindWalk. \"We are\nselling infrastructure into regulated life sciences workloads, and the\ncredibility of that position rests as much on the quality of our governance as\non the quality of the science. Kim has spent 35 years inside regulated\nfinancial institutions as a bank director and licensed fiduciary, and he\nbrings that governance discipline to our Board and its committees. We are\npleased to welcome him to the Board.\"\n\n\"MindWalk is building foundational infrastructure for life sciences AI and\nholding itself accountable for how that infrastructure is governed. That is a\ndiscipline I recognize from the institutional side of finance,\" said Mr.\nRemizowski. \"I look forward to working with Dr. Bath, the Chair, and my fellow\ndirectors, and to bringing the rigor of regulated financial oversight to the\nBoard's committees as the Company scales.\"\n\nAbout Kim Remizowski\n\nMr. Remizowski, a Caymanian, has more than 35 years of experience in\ninstitutional banking and fiduciary oversight. Most recently, he served as\nDirector, Private Equity at Vistra, a global corporate services group\noperating in more than 50 jurisdictions, where he oversaw governance for a\nportfolio of investment funds and holding structures and worked across a\nnetwork of fund sponsors, institutional allocators, and family offices in\nNorth America, Europe, Latin America, and the Caribbean.\n\nPreviously, Mr. Remizowski served as Resident Director of Merrill Lynch Bank\nand Trust Company (Cayman) Ltd., Bank of America Merrill Lynch's Cayman Class\nB bank, with overall responsibility for the bank's operation, including its\nloan, deposit, and investment businesses and all regulatory and financial\nreporting to CIMA. He sat on the bank's Board as Director and Secretary, held\ncredit approval authority for international securities-based loans above $10\nmillion, and was a director and authorized signatory of numerous Merrill Lynch\nlegal entities. He also served as Managing Director of DMS Bank & Trust\nLtd., with responsibility for the bank's strategic direction, operations,\nfinance, and compliance, and at Intertrust Group (now CSC), where he led the\nPrivate Client Trust & Corporate team, with $700 million in assets under\nmanagement. Earlier, he was Manager, Banking, Treasury & Operations at\nAall Trust & Banking Corporation, where he was a member of the Executive\nCommittee. He began his career at Royal Bank of Canada, where over 17 years he\nadvanced through branch management, inspection, and operations roles to\nregional responsibility for 13 branches.\n\nMr. Remizowski is an Accredited Director of the Chartered Governance Institute\nof Canada, a Licensed Director with CIMA, a Trust and Estate Practitioner\n(TEP) with STEP, an Associate of the Institute of Canadian Bankers, and a\nCertified Digital Asset Advisor. He maintains an active professional interest\nin the governance of emerging technologies, including artificial intelligence\nand digital assets.\n\nAbout MindWalk Holdings Corp.\n\nMindWalk Holdings Corp. (NASDAQ: HYFT) is a Bio-Native AI company building the\nBioIntelligence infrastructure that life sciences AI and agentic AI require,\nintegrating AI, data, and advanced wet lab capabilities into one connected\ndiscovery ecosystem. At its core is HYFT® Technology, a proprietary,\nfunction-aware representation of biology. Its HYFT fingerprints span sequence\nand structural biology and, refined over 20 years of curation, form a\ncontinuously evolving biological representation of 660 million patterns and 25\nbillion relationships. This enriched biological representation is the\narchitecture behind ReefIQ™, the biological data substrate that provides\ncontext for life sciences, enriching data at ingestion and growing more\nvaluable with each program run on it, and LensAI™, the reasoning and\napplication layer for target discovery, candidate diligence, portfolio\ndecision support, and the agentic AI workflows pharma is racing to deploy. By\ndesign, value compounds in this HYFT representation layer, not in any\nindividual AI model that runs on top of it.\n\nForward-Looking Statements\n\nThis press release contains forward-looking statements within the meaning of\napplicable United States and Canadian securities laws. Forward-looking\nstatements are based on management's current expectations and assumptions and\nare subject to known and unknown risks, uncertainties, and other factors that\nmay cause actual results to differ materially, including: the ability of newly\nappointed directors to contribute to governance, oversight, and strategic\ndirection as anticipated; the risk that a director resigns, is not re-elected,\nor is unable to serve; the Company's ability to maintain compliance with\nNasdaq listing standards, including independence and committee composition\nrequirements; the Company's ability to convert engagement into contracted,\nrecurring platform arrangements and to retain and expand those arrangements;\nthe Company’s ability to attract and retain qualified independent directors;\nthe build-out and certification of compliance and governance capabilities for\nregulated life sciences workloads; market acceptance and commercial outcomes\nof ReefIQ™ and LensAI™; the technical performance of AI-based discovery\nmethods and of the underlying compute infrastructure; intellectual property\nrisks, including the ability to obtain, maintain, defend, and enforce patent\nand other proprietary rights; competition; regulatory determinations; and\ncapital markets, economic, and geopolitical conditions. Additional information\nabout these and other risks is available under “Risk Factors” in\nMindWalk's most recent Annual Report on Form 20-F and other filings on SEDAR+\n(sedarplus.ca) and EDGAR (sec.gov/edgar). Except as required by law, MindWalk\nundertakes no obligation to update any forward-looking statement. Nothing in\nthis press release constitutes investment advice. This press release does not\nconstitute an offer to sell or the solicitation of an offer to buy any\nsecurities.\n\nTrademarks\n\nHYFT® is a registered trademark of MindWalk Holdings Corp. LensAI™ and\nReefIQ™ are trademarks of MindWalk Holdings Corp. or its subsidiaries;\nReefIQ™ registration is pending. All other trademarks are the property of\ntheir respective owners.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20261001631178/en/\n(https://www.businesswire.com/news/home/20261001631178/en/)\n\nInvestor Relations Contact \n\nLouie Toma, CPA, CFA\n\nManaging Director, CoreIR\n\ninvestors@mindwalkai.com (mailto:investors@mindwalkai.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-10-01T12:46:00.129905226Z","server_sent_at_ms":1790858760129},"received_at":"2026-10-01T12:46:00.222Z","source_url":"https://www.businesswire.com/news/home/20261001631178/en/"},"analysis":{"id":"146864","press_release_id":"158228","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"board_change","narrative":"MindWalk Holdings (NASDAQ: HYFT) appointed Kim Remizowski to its Board as an independent director, effective September 29, 2026, expanding the Board to four directors, three of them independent.\n\nRemizowski brings over 35 years of institutional banking and fiduciary oversight experience, including roles at Vistra, Merrill Lynch Bank and Trust (Cayman), DMS Bank & Trust, and 17 years at Royal Bank of Canada, and qualifies as an audit committee financial expert under SEC rules.\n\nThe appointment coincides with the company's push into regulated life sciences workloads via ReefIQ and LensAI, where governance depth supports credibility with enterprise clients.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine governance strengthening -- audit committee financial expert added as MindWalk scales regulated life sciences deployments."},"keyFigures":{},"quotedText":"Kim brings the kind of governance depth that becomes load-bearing exactly when a company moves from building technology to deploying it at scale","namedEntities":{"people":[{"name":"Kim Remizowski","role":"Independent Director; Audit Committee and Compensation, Nomination and Governance Committee member"},{"name":"Jennifer Bath, PhD","role":"President and CEO"},{"name":"Louie Toma, CPA, CFA","role":"Managing Director, CoreIR (Investor Relations)"}],"products":["ReefIQ™","LensAI™","HYFT® Technology"],"companies":[{"name":"MindWalk Holdings Corp.","ticker":"HYFT","relationship":"filer"},{"name":"Vistra","relationship":"Remizowski's most recent employer (corporate services group)"},{"name":"Merrill Lynch Bank and Trust Company (Cayman) Ltd.","relationship":"prior board service"},{"name":"DMS Bank & Trust Ltd.","relationship":"prior employer"},{"name":"Royal Bank of Canada","relationship":"prior employer (17 years)"},{"name":"Intertrust Group (now CSC)","relationship":"prior employer"}],"dollarAmounts":[{"amount":"$10 million","context":"credit approval authority threshold for international securities-based loans"},{"amount":"$700 million","context":"assets under management of Private Client Trust & Corporate team at Intertrust"}]},"materialImpact":{"score":1,"reasoning":"Routine board appointment adding one independent director with audit committee financial-expert credentials. No change in strategy, control, or financials; boilerplate corporate-governance update."},"tickerRelevance":{"others":[],"primary":"HYFT"},"globalImportance":10,"audienceRelevance":12,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"routine-board-appointment","householdBrandBoost":0,"retailFavoriteBoost":0}},"event_type":"board_change","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"MindWalk Holdings (NASDAQ: HYFT) appointed Kim Remizowski to its Board as an independent director, effective September 29, 2026, expanding the Board to four directors, three of them independent.\n\nRemizowski brings over 35 years of institutional banking and fiduciary oversight experience, including roles at Vistra, Merrill Lynch Bank and Trust (Cayman), DMS Bank & Trust, and 17 years at Royal Bank of Canada, and qualifies as an audit committee financial expert under SEC rules.\n\nThe appointment coincides with the company's push into regulated life sciences workloads via ReefIQ and LensAI, where governance depth supports credibility with enterprise clients.","key_figures":{},"named_entities":{"people":[{"name":"Kim Remizowski","role":"Independent Director; Audit Committee and Compensation, Nomination and Governance Committee member"},{"name":"Jennifer Bath, PhD","role":"President and CEO"},{"name":"Louie Toma, CPA, CFA","role":"Managing Director, CoreIR (Investor Relations)"}],"products":["ReefIQ™","LensAI™","HYFT® Technology"],"companies":[{"name":"MindWalk Holdings Corp.","ticker":"HYFT","relationship":"filer"},{"name":"Vistra","relationship":"Remizowski's most recent employer (corporate services group)"},{"name":"Merrill Lynch Bank and Trust Company (Cayman) Ltd.","relationship":"prior board service"},{"name":"DMS Bank & Trust Ltd.","relationship":"prior employer"},{"name":"Royal Bank of Canada","relationship":"prior employer (17 years)"},{"name":"Intertrust Group (now CSC)","relationship":"prior employer"}],"dollarAmounts":[{"amount":"$10 million","context":"credit approval authority threshold for international securities-based loans"},{"amount":"$700 million","context":"assets under management of Private Client Trust & Corporate team at Intertrust"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-01T12:46:05.511Z","global_importance":10,"audience_relevance":12,"importance_components":{"tickerTier":"small-cap","eventGravity":"routine-board-appointment","householdBrandBoost":0,"retailFavoriteBoost":0}},"durationMs":5401,"modelName":"glm-5.3-flashx"}}